Patent Assignment
Reel/Frame 054646/0615
Assignment of Assignor's Interest
Recorded: 2020-12-15
Pages: 5
Assignor
DYNAVAX TECHNOLOGIES CORPORATION
Executed: 2020-07-31
Assignee
SUREFIRE MEDICAL, INC. D/B/A TRISALUS LIFE SCIENCES
6272 WEST 91ST AVENUE, WESTMINSTER, COLORADO, 80031
Covered Property
(1)
Combination of a Pd-1 Antagonist and Cpg-C Type Oligonucleotide for Treating Cancer
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 4, 2020
From: YU, YING; DENKER, ANDREW EVAN; SADEKOVA, SVETLANA; PHAN, UYEN TRUONG
To: MERCK SHARP & DOHME CORP.; DYNAVAX TECHNOLOGIES CORPORATION
Reel/Frame 054299/0756 →
Change of Name
Oct 27, 2021
From: SUREFIRE MEDICAL, INC. D/B/A TRISALUS LIFE SCIENCES
To: TRISALUS LIFE SCIENCES, INC.
Reel/Frame 057943/0686 →
Merger
Jan 3, 2023
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 062264/0846 →
Security Interest
Apr 30, 2024
From: TRISALUS LIFE SCIENCES, INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP
Reel/Frame 067274/0733 →